Diabetic ketoacidosis is a life-threatening condition caused by insulin deficiency and resistance, leading to excessive production of ketoacids by the liver and metabolic acidosis. It commonly affects older dogs and cats and has an acute onset of lethargy, vomiting, and dehydration. Treatment involves aggressive fluid therapy, insulin administration, and electrolyte replacement to slowly correct blood glucose and acidosis over 24-48 hours, monitoring for complications like hypoglycemia. Long-term management focuses on insulin therapy, diet, exercise and monitoring to control blood glucose levels.
acute complication of diabetes mellitus. cardinal biochemical features for DKA. pathophysiology of DKA. clinical assesment of DKA. investigation and management for DKA. complications of DKA.
Diabetic ketoacidosis is a serious complication of diabetes that occurs when your body produces high levels of blood acids called ketones. The condition develops when your body can't produce enough insulin.
When your cells don't get the glucose they need for energy, your body begins to burn fat for energy, which produces ketones. Ketones are chemicals that the body creates when it breaks down fat to use for energy. The body does this when it doesn’t have enough insulin to use glucose, the body’s normal source of energy. When ketones build up in the blood, they make it more acidic.
Definition of diabetes - introduction - classification of diabetes - etiology of diabetes type 1 and type 2- risk factors for diabetes - diagnosis of diabetes - clinical manifestations of diabetes type 1 and type 2- investigations for diabetes - treatment of diabetes - non-pharmacological treatment and pharmacological treatment - pharmacotherapy of type 1 and type 2 - acute complications of diabetes and treatment
acute complication of diabetes mellitus. cardinal biochemical features for DKA. pathophysiology of DKA. clinical assesment of DKA. investigation and management for DKA. complications of DKA.
Diabetic ketoacidosis is a serious complication of diabetes that occurs when your body produces high levels of blood acids called ketones. The condition develops when your body can't produce enough insulin.
When your cells don't get the glucose they need for energy, your body begins to burn fat for energy, which produces ketones. Ketones are chemicals that the body creates when it breaks down fat to use for energy. The body does this when it doesn’t have enough insulin to use glucose, the body’s normal source of energy. When ketones build up in the blood, they make it more acidic.
Definition of diabetes - introduction - classification of diabetes - etiology of diabetes type 1 and type 2- risk factors for diabetes - diagnosis of diabetes - clinical manifestations of diabetes type 1 and type 2- investigations for diabetes - treatment of diabetes - non-pharmacological treatment and pharmacological treatment - pharmacotherapy of type 1 and type 2 - acute complications of diabetes and treatment
to download this presentation from this link
https://mohmmed-ink.blogspot.com/2020/11/diabetic-ketoacidosis.html
Diabetic Ketoacidosis, diabetus type 1 complection. diagnosisi and managment
Diabetes mellitus (DM) is a common, chronic, metabolic syndrome characterized by hyperglycemia as a cardinal biochemical feature. The major forms of diabetes are classified according to those caused by deficiency of insulin secretion due to pancreatic β-cell damage (type 1 DM, or T1DM) and those that are a consequence of insulin resistance occurring at the level of skeletal muscle, liver, and adipose tissue, with various degrees of β-cell impairment (type 2 DM, or T2DM). T1DM is the most common endocrine-metabolic disorder of childhood and adolescence, with important consequences for physical and emotional development. Individuals with T1DM confront serious lifestyle alterations that include an absolute daily requirement for exogenous insulin, the need to monitor their own glucose level, and the need to pay attention to dietary intake. Morbidity and mortality stem from acute metabolic derangements and from long-term complications (usually in adulthood) that affect small and large vessels resulting in retinopathy, nephropathy, neuropathy, ischemic heart disease, and arterial obstruction with gangrene of the extremities. The acute clinical manifestations are due to hypoinsulinemic hyperglycemic ketoacidosis. Autoimmune mechanisms are factors in the genesis of T1DM; the long-term complications are related to metabolic disturbances (hyperglycemia).
Type 1 Diabetes Mellitus
Formerly called insulin-dependent diabetes mellitus (IDDM) or juvenile diabetes, T1DM is characterized by low or absent levels of endogenously produced insulin and dependence on exogenous insulin to prevent development of ketoacidosis, an acute life-threatening complication of T1DM. The natural history includes 4 distinct stages: (1) preclinical β-cell autoimmunity with progressive defect of insulin secretion, (2) onset of clinical diabetes, (3) transient remission “honeymoon period,” and (4) established diabetes associated with acute and chronic complications and decreased life expectancy. The onset occurs predominantly in childhood, with median age of 7-15 yr, but it may present at any age. The incidence of T1DM has steadily increased in many parts of the world, including Europe and the USA. T1DM is characterized by autoimmune destruction of pancreatic islet β cells. Both genetic susceptibility and environmental factors contribute to the pathogenesis. Susceptibility to T1DM is genetically controlled by alleles of the major histocompatibility complex (MHC) class II genes expressing human leukocyte antigens (HLAs). It is also associated with autoantibodies to islet cell cytoplasm (ICA), insulin (IAA), antibodies to glutamic acid decarboxylase (GADA or GAD65), and ICA512 (IA2). T1DM is associated with other autoimmune diseases such as thyroiditis, celiac disease, multiple sclerosis, and Addison disease. There is some suggestion that high dietary intake of omega-3 polyunsaturated fatty acids and vitamin D supplementation in early childhood decreases the incidence of autoi
A comprehensive presentation on Diabetes Mellitus for undergraduate students from medical /dental/biotechnology /pharmacology education.It describes causes, classification, symptoms ,diagnostic biochemical tests,biochemical changes in metabolism,Management, drugs used for DM .Google images relevant to text are presentation.
2. What is Diabetic Ketoacidosis (DKA)?
Life-threatening metabolic condition
Result of insulin deficiency and resistance
Excessive production of ketoacids by the liver
Leads to metabolic acidosis, hyperosmolality,
electrolyte imbalances, systemic illness
http://petdiabetes.wikia.com/wiki/Ketoacidosis
3. Etiology and Pathophysiology
Shift in hepatic metabolism
from fat synthesis to fat
oxidation and ketogenesis
produces ketone bodies
(acetoacetic acid, β-
hydroxybutyric acid,
acetone)
Insulin deficiency and
resistance leads to
increased production of
ketones
Lipolysis increases, thus
more FFAs are available for
the liver to produce ketones
http://petdiabetes.wikia.com/wiki/Ketoacidosis
4. Etiology and Pathophysiology
Accumulation of ketones overwhelms the body’s
buffering system leading to metabolic acidosis
Renal tubules are unable to have complete
resorption leading to ketonuria
Osmotic diuresis ensues leading to increased loss of
Na+, K+ in urine
Loss of electrolytes and fluid through urine and
vomiting leads to azotemia, cellular dehydration
5. Common Signalment
Older dogs (7-9) and cats
(9-11)
Female dogs 2x > males
Male cats > females
Multiple dog breeds
commonly affected include:
Schnauzer, Poodle, Bichon
Frise, Keeshond
Cats: no breed disposition
thepawblog.com
blog.halopets.com
www.ehow.com
6. Pertinent History
May or may not be a previously diagnosed
diabetic
Have shown signs of diabetes including
PU/PD, weight loss despite increased
appetite
Recent history includes vomiting, weakness,
anorexia
7. Physical Exam Findings
Dehydration-often moderate to
severe
Weakness
Respiratory pattern changes:
tachypnea or Kussmaul’s
respiration (slow, deep
breathing)
Abdominal pain (associated
with pancreatitis)
Strong acetone odor to breath
(sweet smell)
Cataracts (more common in
dogs)
Diabetic neuropathy (dropped
hocks, more common in cats)
8. Diagnostics
Complete blood count
Biochemical profile
Electrolyte panel
Urinalysis and culture
Radiographs, ultrasound, and further
diagnostics may be needed
9. Results
CBC
– Variable, may show high white blood cells
Profile
– High blood glucose, low sodium, low potassium
– High cholesterol
– Liver enzyme elevation
– Azotemia
Urinalysis
– Positive ketones
– Glucosuria
– Pyuria and bacteria common if concurrent UTI
cPL positive if concurrent pancreatitis
10. Treatment-Fluid Therapy
Crystalloid, type based on electrolytes
Supplement with potassium
– Usually 30-40 mEq/L
Supplement phosphorus if <1.5mg/dL
– Necessary to avoid hemolytic anemia
Add 2.5-5% dextrose to fluids once BG
approaches 250 mg/dL
11. Treatment-Insulin
Begin after starting fluid therapy
Intermittent IM technique:
– 0.2 U/kg IM initially
– Then, 0.1 U/kg IM hourly
Insulin CRI
– 0.05 U/kg/h (cat) 0.1 U/kg/h
(dog) in 0.9% NaCl
Adjustments made based on
BG
– Switch to every 0.1 U/kg 6 to 8
h SQ once BG ~ 250 mg/dL
Goal is to slowly decrease BG
until between 100-300 mg/dL
12. Treatment-Other
Bicarbonate supplementation
– Use with caution
– Supplement if bicarb is < 12mEq/L
– HCO3
-
= body weight (kg) x 0.4 x (12 - patient’s HCO3
-
) x 0.5
– Add to fluids and given over 6 h
Anti-emetics if needed to control vomiting
Nutrition: Very important to encourage patient’s to
eat to avoid hypoglycemia
Antibiotics: Many patients have concurrent UTIs
13. Monitoring
Frequent blood glucoses
– Initially every 1 to 2 hours
– May begin to decrease when BGs stabilize
Hydration status
– Monitor inputs (fluids) and outputs (urine, vomit, diarrhea)
– Make adjustments as needed
Electrolyte concentrations
– Adjust fluids and additives as necessary
Patient’s weight, temperature, blood pressure
14. Potential complications
Goal is to correct blood glucose, acidosis,
and electrolyte abnormalities SLOWLY (24-
48 hours)
Hypokalemia, hypoglycemia, hypernatremia,
hemolytic anemia commonly occur
Neurologic signs related to cerebral edema
15. Long-term Care and Follow-up
Treat concurrent diseases
– Urinary tract infections
– Diarrhea
– Pancreatitis
– Cushing’s disease
Establish good control over
blood glucose levels
– Regular check-ups
– Blood glucose curves to help
establish insulin dose
free-glucose-meter.com
16. Long-term Care and Follow-up
Dietary changes
– Controlled weight loss
– High fiber, low calorie, low-fat
diets
– Hill’s w/d, r/d, or m/d, Purina’s
OM or DM, other senior or
weight loss diets
– Avoid giving treats or snacks
high in fat and sugar
Encourage regular exercise
findavet.us
17. At home care and monitoring
Owners of diabetics need to be aware of
DKA and its life-threatening nature
Have owners contact a veterinarian if:
– Patient is vomiting or having diarrhea
– Stops eating
– Becomes lethargic
– Urine and/or breath smells “funny”
18. DKA on ER
May be a stat triage-many of these patients
are very ill
Brief history from owner-if known diabetic,
ask about insulin, when and how much last
given and has patient been eating
Ask permission for IV catheter, diagnostics
(about $150 to $200 to start)
19. Once in treatment room
Obtain blood for CBC/profile
and a urine sample
Run an I-stat 8
– Glucose, pH, electrolytes
Check urine dipstick
– Look for ketonuria (if
negative, does NOT rule
out DKA)
Place IV catheter
Prepare fluids
http://www.clickmdlab.com
http://www.bidbuy.co.kr
20. Sources
Côté, Etienne (ed): Clinical Veterinary
Advisor. St. Louis, Mosby, Inc. 2007.
Hill’s Key to Clinical Nutrition 2007-2008.